Study of Safety and Efficacy of HLX01+MTX in Patients With Rheumatoid Arthritis
Clinical trial NCT03522415 · COMPLETED
Trial details
- NCT number
- NCT03522415
- Sponsor
- Shanghai Henlius Biotech
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-28
- Primary completion
- 2020-04-05
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.